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Abstract
Background: Maintained study-based registers (SBRs) have, at their core, study records linked to, potentially, multiple
other records such as references, data sets, standard texts and full-text reports. Such registers can minimise and refine
searching, de-duplicating, screening and acquisition of full texts. SBRs can facilitate new review titles/updates and,
within seconds, inform the team about the potential workload of each task.
Methods: We discuss the advantages/disadvantages of SBRs and report a case of how such a register was used
to develop a successful grant application and deliver results—reducing considerable redundancy of effort.
Results: SBRs saved time in question-setting and scoping and made rapid production of nine Cochrane systematic
reviews possible.
Conclusion: Whilst helping prioritise and conduct systematic reviews, SBRs improve quality. Those funding information
specialists for literature reviewing could reasonably stipulate the resulting SBR to be delivered for dissemination and
use beyond the life of the project.
Keywords: Study-based registers, Grant application, Systematic reviews, Research prioritisation, Reducing waste,
Increasing value
Background
Time to complete systematic reviews
There is much redundancy in medical research [1–6] and
systematic reviewing is no exception [7–18]. Usually, the
review team runs searches, removes duplicates, screens
titles and abstracts, obtains full-text reports, screens full
texts, assembles reports of the same study, extracts data,
synthesises them and writes the final report. This process
has great potential for waste [19–21]. For systematic
reviews, the median time from search to publication has
improved from 14months in 2008 [22] to 8 in 2013 [23]
(mean time to complete was 17months [24]; median time
between first search and appearance of the review in
PubMed was nearly 2 years [25]). The Cochrane Collabo-
ration, a large organisation undertaking and maintaining
systematic reviews of health care, largely works with
volunteer health care professionals [26, 27] and the
median time from Cochrane protocol to review publica-
tion was 2.4 years [28]. Keeping volunteer authors active
on the review and the actual length of the review process
are two major challenges to swift reviewing [29]. Efficien-
cies are needed.
Current preparation for reviewing
At the start of a new systematic review or an update for
an existing systematic review, there is limited knowledge
about the quantity of relevant literature. Although esti-
mation of workload is possible through piloting or scoping
searches [30–32], this requires time and the exact number
of relevant studies may remain unclear. This lack of clarity
leaves assembled review teams vulnerable. The predicted
investment of effort could be
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 Overestimated—and eventually review teams
have no or very few studies for their new review
or update—with the waste this would incur.
 Underestimated—and the team is eventually
surprised and, perhaps, overwhelmed with many
relevant studies, with the risk of
Publishing a protocol but finding completion
of the review unaffordable or impossible with the
resulting wasteful unfinished or empty review.
Requesting extensions to funding; and/or
Running into delays that may render the
final work being immediately out of date.
 Accurately estimated—but what remains unclear
is as to whether the investment needed to review/
update is warranted by any potential to change
what is already known.
Waste in systematic reviewing and information supply
The majority of the literature related to waste in sys-
tematic review are either focused on methodology [7–18]
or automation of processes to shorten time-consuming
tasks [33–36]. For over two decades, information spe-
cialists have given practical guidance for waste reduction
in systematic reviews [32, 37–41]. Information specialists
in the Cochrane Collaboration maintain specialised
registers to support Cochrane reviews. Some of these
registers are highly developed and shorten the systematic
review process [42].
Study-based registers
Study-based registers (SBRs) are databases in which all
records of same study are linked to one ‘parent’ report.
This study report may contain meta-data extracted from
the various ‘child’ records of that same study. Often
building a SBR involves an information specialist
running searches across major bibliographic databases,
de-duplicating, screening for eligibility, and obtaining
full text of records. Then, there is the process of linking
‘child’ reports to the parent study record, extracting,
cleaning and curating meta-data and maintaining the
register with updates. In the case of randomised trials,
meta-data for the study may be gleaned from the indi-
vidual records (e.g. details of participants, interventions,
controls and outcomes (PICO)) or, working from the
other direction, from the overarching review in which
the study has been used (e.g. qualitative or quantitative
data incorporated within the review relating to that
study). Details of creating and maintaining a SBR has
been reported elsewhere [42].
Aims and objectives
To describe how a SBR can be used to almost eliminate
certain arduous steps in prospective systematic reviewing.
We will illustrate how these steps can be accomplished in
a matter of minutes or seconds and how this approach
almost negates the early, inhibiting, and, we argue,
wasteful, effort experienced by systematic reviewers.
Although some benefits of SBRs have already been re-
ported [42, 43], little has been presented on how SBRs can
reduce waste whilst assisting prioritisation of systematic
review work [44].
‘Living’ study-based registers
With a well-maintained SBR, an information specialist
can provide the following data in a matter of minutes
(stipulation of all estimates are review-specific but
worked example follows):
 Exact number of
Studies/related records in a field
(e.g. schizophrenia, tardive dyskinesia);
Studies/related records relevant to a new
title or update (e.g. vitamin E for people with
tardive dyskinesia);
Studies/related records relevant to a class
of interventions (e.g. calcium channel blockers);
Studies that have/have not already been
data-extracted, and the extracted data
were available;
Existing related reviews on a topic—and
quantification of studies/related records within
each review;
Comparisons possible to accurately
scope existing relevant evidence on a given
topic—and quantification of studies/related
records within each comparison [45];
 Alerts to
New studies, records to known studies
and novel relevant treatments;
Research gaps in topic areas devoid
of/with a dearth of evidence;
 For the studies
Concatenated importable references, the
output of each study or all the relevant studies;
Full reports of each studies collected into a
study folder;
Completed data extraction forms of studies
where available.
Essentially, a SBR should be ‘living’. These living
curated registers involve minimal analyses and are main-
tained by an information specialist (Table 1). Such regis-
ters have been produced by the Cochrane Dementia
(ALIOS), Renal/Kidney (maintained within MeerKat),
Pregnancy and Childbirth, Stroke (DORIS) and Schizo-
phrenia (within MeerKat) teams for over two decades.
For some existing SBRs, there is further developments
to add functions to include extracted data from reviews
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[42], links to standard text and to prioritise sharing these
data publicly [46]. Unfortunately, CENTRAL and Cochrane
Register of Studies (CRS) are, at best, rudimentary SBRs at
the time of revising this paper (27 March 2019).
Armed with the information from these sophisticated
registers a potential review team should be able to
present a much more accurate estimate of workload
before embarking on the grant application or the actual
review or update. These registers should make it possible
to truncate the period immediately after protocol publi-
cation, seeding the systematic review with extracted data
and preparing for swift meta-analysis.
A case report from schizophrenia
Cochrane Schizophrenia has maintained a SBR of rando-
mised trials for over two decades [47]. Routine searching
identifies records that, with some help from automation,
are merged into study reports (examples of studies with
10, 50 or even 100 records are not rare) helping mini-
mise the risk of multiple counting with the systematic
review. Meta-data (including number randomised) are
part of the study record. Although increasingly auto-
mated, this process is facilitated by the group’s infor-
mation specialist (FS). Since search strategies have been
saved in bibliographic databases, monthly automatic up-
dates are received through email. Then the information
specialist spends three days per month for routine pro-
cesses of updating the register: (1) 1 day for primary
screening of search results and adding references to the
register; (2) another day for obtaining full texts and
linking them to their references; and finally (3) one last
day for indexing the PICO meta-data from each full text
and then assembling the separate references of the same
study and linking them to that study. This register
supports 324 maintained systematic reviews (17 May
2019).
Using this SBR, prioritisation of work could then
proceed with efficiency (Fig. 1) and in line with items
2–6 from module 2 of SPARK, a prioritisation tool
for systematic reviews [48].
Estimates of costs for the grant application
In applying for NIHR UK Health Technology Assessment
(HTA) Project Grant (14/27/02) [49–51], a call for reviews
relevant to treating people with Tardive Dyskinesia (a
problematic adverse effect of antipsychotic drugs) use of
the SBR gave a clear advantage. Cochrane Schizophrenia’s
information specialist ran a highly specific, highly sensitive
search (16 July 2015) in the SBR and identified the exact
number of studies relevant to the problem (time spent on
task 8 s). This number helped the grant application
team provide an accurate assessment of the work to
be done—and realistic estimates of costs.
Prediction of best composition of families of reviews
Tardive Dyskinesia is a condition for which many treat-
ments have been used [52]. Arguments exist for ‘lumping
and splitting’ at all sorts of levels. At the broadest level of
‘lumping’, the overview could encompass all treatments
but this becomes unwieldy and impossible to update. At
Table 1 Saved resource by use of study-based registers by stage of systematic reviewing
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the finest level of ‘splitting’ each individual comparison of
each treatment could be treated as a separate review. Even
in a limited topic area such as Tardive Dyskinesia, this
would lead to hundreds of separate reviews. Clearly there
is a balance to be struck. By use of a controlled vocabulary
for the meta-data within the SBR auto-grouping into
logical treatment/comparison families for reviews can take
place—and, once established, this can take place instantly.
This ensures a pragmatic middle road dividing work into
clinically logical bite-size reviews for later overviewing if
required. Also, the classification of interventions within
the register allows reviewing a class of interventions in a
review. In the case of Tardive Dyskinesia, 10 separate re-
view groupings were created (Table 2) (time spent on task
2min and 10 s). This also helped the grant application
team provide an accurate assessment of the output the
funders could expect.
Prediction of effort needed at data extraction step and
saving effort for others
In this particular case, the SBR also contains information
on already extracted data. Therefore, the applicants were
also informed of exactly how much work has been com-
pleted and allowed them to make accurate costing for the
Fig. 1 The process of systematic reviewing using a study-based register
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necessary remaining efforts (time spent on the task 8 s).
Working with such a register affords applicants opportu-
nities to ensure that their request for funding for this part
of the effort can be seen as an investment. The extracted
study data can, thereafter, be made available to anyone
thus reducing future duplication of effort (see below).
Supply of documents
SBR systems such as Microsoft Access ‘MeerKat’ [64–66]
have capacity to output file batches grouped by review,
sub-grouped into relevant study files, in turn containing
all relevant records and references (time spent on the task
4min and 43 s). In this cause, this allowed those applying
for the grant to reassure funders that supply of documents
was not an issue and, once the grant was given, to waste
no time in acquiring papers and piecing together the stud-
ies from ‘salami’ or multiple publications of same study.
Future supply of full dataset
In the hope of evolving SBR towards making the level of
document supply described above redundant and saving
more time in the future—applicants sought and were
granted support to extract all data from all randomised
studies relevant to Tardive Dyskinesia and to make these
data publicly available. This included each part of the
data being made traceable to the exact site within the
source record [67]. Any new updates of this will involve
supply of documents containing tabulated, reliably and
verifiably extracted data [50].
Updating
Cochrane recommends biennial update for reviews [68]
but this timing is not always appropriate. Excessive
updating wastes resource while inadequate updating
could result in outdated or incomplete evidence being
used [69]. While there are methods to detect if up-
dating a review could change the current conclu-
sion/practice, almost all require an awareness of the
available ‘unused’ relevant literature [48, 70–99], and
some degree of screening and data checking to allow
an informed decision. Within a well-constructed and
maintained study register, this investment has already
been made.
The upside
As the grant [49] was drawing to a close and the reviews
were being completed. On the 26 April 2017, the SBR
allowed the information specialist to run a final ‘just-be-
fore-submission’ update search limiting to not-already-
identified records (time spent on the task 13 s). Just
before publication, this search was used to inform the
team that seven of the 10 reviews were fully current but
two needed to be updated with a total of five new
studies. This allowed the grant holders efficiently update
the reviews just pre-publication to ensure they held fully
current information.
The downside
This search also identified two new drugs (Valbena-
zine and Deutetrabenazine) entering the market specif-
ically for treatment of people with Tardive Dyskinesia.
These new compounds, unrelated to others, necessitate a
new review outside of what was supported by the grant
[62]. Unlike the decades ago when SBRs did not
exist or were not sophisticated, it is now almost im-
possible to fail to identify a newly emerging treat-
ment. This saves further waste in systematic reviews
through inclusiveness of all treatments from all
classes.
Feasibility of study-based registers
Although it seems exciting to start a systematic review
with the extraction of data, the workload creating a SBR
should not be underestimated. The investment of time is a
frequent concern. Is it possible for all evidence-synthesis
groups to maintain a SBR and what are the necessary
requirements in creating such a register?
The short answer is that every systematic review is, in
itself, a small SBR. Frequently at completion of any given
review, these small registers (reviews) are rendered
unusable to others or disassembled necessitating the
next interested group of reviewers to have to repeat the
construction. This is avoidable waste when collating all
the data within a related group of reviews constitutes
the embryonic SBR.
Table 2 Updated/started Cochrane reviews as a result of NIHR
HTA Grant (14/27/02) [49]
Anticholinergic medication for antipsychotic-induced tardive dyskinesia [53]
Antipsychotic reduction and/or cessation and antipsychotics as specific
treatments for tardive dyskinesia [54]
Benzodiazepines for antipsychotic-induced tardive dyskinesia [55]
Calcium channel blockers for antipsychotic-induced tardive dyskinesia [56]
Cholinergic medication for antipsychotic-induced tardive dyskinesia [57]
Gamma-aminobutyric acid agonists for antipsychotic-induced tardive
dyskinesia [58]
Miscellaneous treatments for antipsychotic-induced tardive dyskinesia [59]
Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive
dyskinesia [60]
Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesiaa [61]
Vesicular monoamine transporter inhibitors versus placebo for
antipsychotic-induced tardive dyskinesiab [62]
Vitamin E for antipsychotic-induced tardive dyskinesia [63]
aThis review is absent in the published report [51] because there was no
new study
bThis review is absent in the published report [51] because we became
informed and started this review as a result of update search process in SBR
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In Table 3, we itemise the time and resource required
for establishing and maintaining our broad-based
schizophrenia SBR.
Conclusions
Small SBRs, in the form of competed reviews, are in-
creasingly prevalent. We maintain that there is a strong
argument for creation of broad-based healthcare
study-based registers linked to records containing data,
text and other relevant information. Not to use already
compiled data is wasteful and not to invest to create the
SBR is passing cost—and waste—down the line to re-
viewers. Information specialist investment is already
happening—repeatedly. We argue that focus and di-
rection of this investment would avoid the ongoing un-
necessary multiplication of effort [101].
We reported one example of the potential of SBRs for
grant application. This is one amongst many. The living
property of this register allowed the information
specialist with his/her more sophisticated role—to be-
come an integral—and useful—part of the review team.
Finally, the SBR promoted more sophisticated sharing
of data from this project facilitating the not-so-distant
full automation of living systematic reviews.
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